Stock comparison

JNJvsNVDA

Johnson & Johnson vs NVIDIA Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JNJ

Johnson & Johnson

$234.18

+16.15%

Pharmaceuticals$585.7BNYSE
NVDA

NVIDIA Corp

$201.68

+5.85%

Semiconductors$4.34TNASDAQ

60-day price, rebased to 100

JNJ +7.18% · NVDA +5.52%

Round-by-round

JNJ 3·NVDA 3
EdgeJNJ

Valuation upside

-49.50% vs -98.20% to DCF fair value

EdgeNVDA

Balance-sheet strength

Altman Z 5.48 vs 512.92

EdgeNVDA

Fundamental quality

Piotroski 4.00 vs 6.00 (of 9)

EdgeJNJ

Growth + margins

Rule-of-40 -5.70 vs -6.80

EdgeJNJ

60-day momentum

+7.18% vs +5.52% price return

EdgeNVDA

Market-cap liquidity

$585.7B vs $4.34T

Verdict

Across 6 categories, the two names are evenly matched — 3 wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on JNJ or NVDA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more